AKAN Akanda Corporation Quarterly EPS earnings growth

akandacorp.com (AKAN) - corporate logo

Akanda is reducing its European assets in a push for profitability within the domestic market. The current quarterly EPS growth rate shows a metric value of 75.10, confirming the profit trend. AI-driven greenhouse robotization is lowering labor costs, while the business's moderate cyclicality relies on the global trend toward the liberalization of the psychotropic substances market.

akandacorp.com (AKAN) Quarterly EPS earnings growth: for the period 04/28/2023 - 11/12/2026

Comprehensive metric breakdowns and analytics for Akanda Inc (AKAN)

- market value and analyst target forecast:
Price Chart Akanda Corp.|AKAN - Consensus Target
- market capitalization data:
Market Capitalization Akanda Corporation|AKAN - Enterprise Value
- balance sheet net asset value indicators:
Net Assets per Single Share Akanda|AKAN - Book Capitalization|Market Capitalization to Book Value Ratio akandacorp.com|AKAN - Company Total Assets
- debt and liquidity data:
Debt to Equity Akanda|AKAN - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital Akanda|AKAN - Company Aggregate Debt|Debts to Book Capitalization Akanda Corporation|AKAN - Company Long-Term Debts|Company Short-Term Debts Akanda|Quick Liquidity akandacorp.com
- earnings and market multiples details:
AKAN - Net Profit|Projected Future Earnings Akanda|AKAN - P/E Multiple|Future Price to Earnings Akanda Corporation|AKAN - Growth-Adjusted P/E Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Akanda Corporation|AKAN - Operating profit before amortization|Net earnings per share (EPS TTM) Akanda|AKAN - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last twelve months akandacorp.com|AKAN - Earnings per share increase in current year|Earnings growth forecast for next year Akanda
Summary company analysis:Akanda Corp. - AKAN
Manufactured product of Akanda Inc

Identifying fundamentally resilient companies requires filtering market noise through an analysis of net earnings per share dynamics. The current quarterly EPS rate of 75.10 measures the percentage change in profit over the period, reflecting the efficiency of Akanda (AKAN) in optimizing its logistics hubs across Europe and Africa while overcoming customs barriers, allowing investors to assess the real value of the business.

Competitor analysis

Indivior (INDV) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months Collegium Pharma|CRON (Cronos) - Quarterly EPS earnings growth|Quarterly EPS earnings growth Canopy Growth Corp.|Year-over-year earnings per share growth for the last twelve months High Tide Inc. (HITI)|Quarterly EPS earnings growth auroramj.com (ACB)|Quarterly EPS earnings growth ACHV (Achieve Life Sciences, Inc.)|Quarterly EPS earnings growth skyebioscience.com SKYE|ANEB - Year-over-year earnings per share growth for the last twelve months|INCR (InterCure Ltd.) - Year-over-year earnings per share growth for the last 12 months|NTRB: Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months NSRX|IGC (India Globalization Capital) - Quarterly EPS earnings growth|Quarterly EPS earnings growth MIRA Pharma|Quarterly EPS earnings growth FLGC|Quarterly EPS earnings growth imcannabis.com (IMCC)|Year-over-year earnings per share growth for the last twelve months Adial Pharmaceuticals, Inc. ADIL|Quarterly EPS earnings growth Artelo Biosciences Inc. ARTL|Ensysce - Quarterly EPS earnings growth|TTNP - Quarterly EPS earnings growth|Greenlane Holdings Inc (GNLN) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last 12 months INM|Year-over-year earnings per share growth for the last twelve months Enveric Biosciences|Year-over-year earnings per share growth for the last 12 months BGXX (Bright Green Corp)|Quarterly EPS earnings growth HPCO